Angela Lowenstern, MD
Interventional Cardiology · Nashville, TNNPI 1235405796
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (48.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 82.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $21,000 and has fallen 54.6% since, to $9,531 in 2025.
Across 81 payments — averaging $531.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$36K
- Edwards Lifesciences$5K
- Boston Scientific$981
- Abbott$590
- Teleflex LLC$274
- Opsens Inc.$181
- plus $287 from 4 others
What the payments were for
- Consulting fees$3,5008%
- Speaking & faculty fees$7,07616%
- Grants$21,00049%
- Travel & lodging$7,03916%
- Food & beverage$4,43210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 31 | $35,652 |
| Edwards Lifesciences | 21 | $5,083 |
| Boston Scientific | 9 | $981 |
| Abbott | 12 | $590 |
| Teleflex LLC | 2 | $274 |
| Opsens Inc. | 2 | $181 |
| Heartflow, Inc. | 1 | $147 |
| Philips North America LLC | 1 | $90 |
| Acist Medical Systems, Inc. | 1 | $26 |
| Novo Nordisk | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$13,496
- HARMONY$426
- AVVIGO Guidance System$302
- EVOQUE$199
- MitraClip$178
- OPTICROSS$173
- NAVITOR$151
- FFRct$147
- GUIDELINER$144
- GENERAL VASCULAR ACCESS$130
- TRAPLINER$130
- OptoWire$113
- SYMPLICITY G3$106
How this compares
$43,047 in reported general payments places this provider in the 80th percentile of 207 interventional cardiology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 25 | $49,963 |
| JardianceEmpagliflozin | 46 | $49,194 |
| Repatha SureclickEvolocumab | 44 | $43,355 |
| EliquisApixaban | 18 | $25,581 |
| XareltoRivaroxaban | 16 | $13,896 |
| FarxigaDapagliflozin Propanediol | 13 | $10,865 |
| Metoprolol Succinate | 52 | $1,043 |
| Atorvastatin Calcium | 87 | $1,026 |
| ClopidogrelClopidogrel Bisulfate | 44 | $648 |
| Ezetimibe | 21 | $562 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 19 | $503 |
| Losartan Potassium | 27 | $444 |
| Rosuvastatin Calcium | 25 | $352 |
| Metoprolol Tartrate | 42 | $315 |
| Amlodipine Besylate | 45 | $307 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Nashville
- Jimmy KerriganNashville$644K
- Kashish GoelNashville$558K
- Brian JeffersonNashville$547K
- Michael MorseNashville$353K
- Nadia SuttonNashville$344K
- Samuel HorrNashville$246K
- Colin BarkerNashville$217K
- Leah RajNashville$88K
- Andrew GoodmanNashville$57K
- Jay PatelNashville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.